Related references
Note: Only part of the references are listed.Defective NKT Cell Activation by CD1d+TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
Michael Nowak et al.
PLOS ONE (2010)
The transcription factor PLZF directs the effector program of the NKT cell lineage
Adam K. Savage et al.
IMMUNITY (2008)
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions
Damian Kovalovsky et al.
NATURE IMMUNOLOGY (2008)
Freshly isolated Vα24+ CD4+ invariant natural killer T cells activated by α-galactosylceramide-pulsed B cells promote both IgG and IgE production
A. Rossignol et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of the function of human invariant NKT cells from cancer patients using α-galactosylceramide-loaded murine dendritic cells
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2006)
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs
ES Morris et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
M Nieda et al.
BLOOD (2004)
Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment
JM Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration
R Dong et al.
BLOOD (2003)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-α
JL Steegmann et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas
NY Crowe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide
K Yanagisawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
MJ Smyth et al.
BLOOD (2002)
TRAIL expression by activated human CD4+Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells
M Nieda et al.
BLOOD (2001)
Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1
M Nakui et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)
Share Paper
